Transzonular vitreous injection vs a single drop compounded topical pharmaceutical regimen after cataract surgery

PURPOSE: To compare the relative effectiveness of a Tri-Moxi-Vanc intraocular solution injected transzonularly into the vitreous with the topical formulation of Pred-Moxi-Ketor (given for the first week postoperatively) followed by Pred-Ketor (given for weeks 2–4 after surgery). PATIENTS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, Bret L, Potvin, Rick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957678/
https://www.ncbi.nlm.nih.gov/pubmed/27486301
http://dx.doi.org/10.2147/OPTH.S112080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957678/
https://www.ncbi.nlm.nih.gov/pubmed/27486301
http://dx.doi.org/10.2147/OPTH.S112080

Ejemplares similares